
4SC expands domatinostat combo testing
In an investigator-initiated Phase Ib study (DONIMI) at NKI, 40 patients with melanoma will be enrolled before surgery (neoadjuvant setting) to...

Ermium Therapeutics bags €6.3m in Series A round
Domain Therapeutics, Kurma Partners, Idinvest, and the SATT Erganeo contributed to the financing. Ermium Therapeutics has licenced exclusively...

Creoptix AG closes CHF8m financing round
The financing round was led by Swisscanto Invest by Zürcher Kantonalbank and joined by Waters Corporation as well as existing private investors....

Meatable NV raises US$10m in seed funding
BlueYard Capital, the Eurostars Programme of the European Commission, and angel VCs Taavet Hinrikus and Albert Wenger (Union Square Ventures)...

BIOncoTech Therapeutics and MSD combine cancer drugs
The clinical collaboration aims at providing clincial Phase II evidence that Bioncotech Therapeutics’ RNA–based cancer lead BO-112 can improve the...

Novo Nordisk enters haemophilia gene therapy field
Changes in the treatment standard of haemophilia A, such as Roche’s 2017 launch of Hemlibra, have put Novo Nordisk’s revenues (in the US$15.8bn...